Figure 3From: Current status of sublingual immunotherapy in the United States9Daily combined scores with 300 IR 5-grass sublingual tablet as a function of specific IgE. Daily CS overall and in sub-groups based on timothy grass-specifc serum IgE at baseline. The number of participants in each group is displayed in each bar. Note: IgE data were not obtained for 1 placebo-treated subject. *P < .001 versus placebo.Back to article page